U.S. FDA authorizes Novavax COVID-19 vaccine for an emergency use in individuals aged 18 and above

(G.N.S) dt. 14 Washington The fourth vaccine available in the United States, the Food and Drug Administration (FDA) issued an emergency use authorization for the Novavax COVID-19 vaccine in individuals aged 18 and above. In a statement, the FDA said the vaccine, whose known and potential benefits outweigh risks in